ORF3b

UniProt ITasser SWISS Models alphafold D3Targets-2019-nCoV

May play a role in interferon antiviral system evasion. SARS-CoV-2 ORF3b is homologous to SARS-CoV ORF3b, although the proposed protein is much shorter due to the presence of premature stop codons. Elicits strong specific antibody response.


Models/PDB

No model built for protein with good structural coverage represented in PDB

Models/PDB Model Chains_ID Selected Templates Model-Quality (MolProbity) PDB Coverage Model Coverage Sequence Length Oligomer States Oligomer Interfaces Model information
ORF3b A 7CZL_e2YEV_F1TDP_A 1.56 0.00% 100.00% 22 monomer

NA

NA


UniProt Viewer


Predictions of Mutations

pdb_id mutations deepddg maestro mCSM_ppi mCSM_Stability imutant provean
orf3b G9Q 0.416 -1.589684 -1.804 -0.628 Decrease -8
orf3b T20R -0.191 -1.49607 -0.52 -0.075 Decrease -6
orf3b F6E -0.007 -1.488943 -0.999 0.756 Decrease -9
orf3b M1N -0.178 -1.405557 -0.464 0.41 Decrease -7
orf3b M1E -0.144 -1.395846 0.197 0.08 Decrease -7
orf3b Y18Q -0.219 -1.370572 -1.491 -0.407 Decrease -8
orf3b Y18R -0.217 -1.365159 -1.738 0.019 Decrease -9
orf3b V22Q -0.241 -1.33537 0.197 -0.568 Decrease -6
orf3b M1D -0.174 -1.317474 0.166 0.144 Decrease -8
orf3b M1Q -0.096 -1.314775 -0.198 0.261 Decrease -5
orf3b V13W -0.126 -1.30671 -0.834 -0.959 Decrease -7
orf3b M1S -0.285 -1.30423 -0.489 0.071 Decrease -6
orf3b F6R -0.243 -1.293418 -1.751 0.247 Decrease -9
orf3b M1P -0.333 -1.282886 -0.63 -0.18 Decrease -7
orf3b V22R -0.23 -1.279542 -0.138 -0.03 Decrease -7
orf3b T15Q -0.535 -1.274866 -0.445 -0.426 Decrease -6
orf3b M2R -0.136 -1.266473 -0.728 0.754 Decrease -6
orf3b F7E -0.327 -1.259664 -1.107 0.769 Decrease -9
orf3b M1R -0.162 -1.259277 -0.585 0.585 Decrease -6
orf3b V17Q -0.431 -1.249107 -0.745 -0.529 Decrease -6
orf3b M2Q -0.107 -1.235236 -0.583 0.398 Decrease -5
orf3b G9K 0.394 -1.234878 -2.258 -0.775 Decrease -8
orf3b V17R -0.542 -1.230217 -1.528 -0.149 Decrease -7
orf3b V22M -0.161 -1.227867 0.32 -0.615 Decrease -3
orf3b I10R -0.564 -1.215743 -0.822 -0.263 Decrease -7
orf3b Y18E -0.276 -1.206183 -1.121 0.932 Increase -9
orf3b T4F 0.081 -1.196165 -0.376 -0.988 Decrease -7
orf3b F6K -0.193 -1.193625 -1.478 -0.149 Decrease -9
orf3b I12Q -0.544 -1.192751 -0.839 -0.521 Decrease -7
orf3b F6Q -0.083 -1.188369 -1.674 -0.183 Decrease -9
orf3b V22K -0.149 -1.182431 0.164 -0.491 Decrease -6
orf3b T15L 0.204 -1.173624 -0.051 -0.1 Decrease -6
orf3b I10Q -0.448 -1.171609 -0.385 -0.68 Decrease -7
orf3b I16R -0.909 -1.170859 -1.129 -0.122 Decrease -7
orf3b G9E 0.566 -1.166372 -1.703 -0.292 Increase -8
orf3b V17E -0.56 -1.162371 -0.748 -0.15 Decrease -6
orf3b T14R -0.499 -1.154173 -0.74 -0.382 Decrease -6
orf3b G9R 0.192 -1.15172 -2.403 -0.658 Decrease -8
orf3b T4M -0.075 -1.138262 0.23 -0.37 Decrease -6
orf3b T20K -0.075 -1.134864 -0.47 -0.243 Decrease -6
orf3b T15R -0.635 -1.132113 -0.889 -0.321 Decrease -6
orf3b V13Q -0.357 -1.124937 -1.09 -0.67 Decrease -6
orf3b M2W -0.007 -1.123419 -0.457 -0.287 Decrease -6
orf3b V22E -0.329 -1.120882 0.635 -0.311 Decrease -6
orf3b T15K -0.391 -1.116378 -0.619 -0.313 Decrease -6
orf3b T14Q -0.37 -1.104944 -0.233 -0.502 Decrease -6
orf3b F7Q -0.346 -1.09621 -1.637 -0.352 Decrease -9
orf3b I12R -0.639 -1.09441 -1.332 -0.039 Decrease -7
orf3b M1K -0.156 -1.092173 -0.272 0.229 Decrease -6
orf3b T4H -0.091 -1.092166 0.311 -0.787 Decrease -7


Protein-Protein Interactions

We have mapped SARS CoV-2 human Protein-Protein Interactions from A SARS-CoV-2 protein interaction map reveals targets for drug repurposing human drug target interacted with SARS CoV-2 are highlighted in black arrow.






Responsive image